| 洛铂对肺癌HTB-56、HTB-56/DDP细胞株生长抑制作用的研究 |
| |
| 引用本文： | 高文斌,邓蓉,韩佩妍,黄剑辉,李花妮,马建增,郑真真,方今女.洛铂对肺癌HTB-56、HTB-56/DDP细胞株生长抑制作用的研究[J].中华肺部疾病杂志（电子版）,2012,5(2):137-140. |
| |
| 作者姓名： | 高文斌 邓蓉 韩佩妍 黄剑辉 李花妮 马建增 郑真真 方今女 |
| |
| 作者单位： | 1. 大连大学附属中山医院肿瘤内科,辽宁大连,116001
2. 延边大学医学部病理及病理生理学教研室,吉林延吉,133002 |
| |
| 基金项目： | CSCO-金港榄香烯肿瘤学研究生奖学助学基金 |
| |
| 摘 要： | 目的探讨不同浓度洛铂(LBP)对肺癌HTB-56、HTB-56/DDP细胞株生长抑制作用的影响,及不同药物浓度对细胞影响之间的关系。方法选择人肺癌HTB-56及其耐DDP细胞株HTB-56/DDP为研究对象,用MTT比色法检测不同浓度LBP作用于腺癌细胞株不同时间的OD值(optical density,光密度),比较药物剂量与其生长抑制效应之间的关系。结果 LBP能够抑制肺癌细胞株HTB-56及其耐DDP细胞株HTB-56/DDP的生长,并呈浓度与时间的依赖关系,随着浓度的升高和时间的延长对两种细胞的抑制率也随之增大。结论 LBP能够显著的抑制HTB-56及其耐DDP细胞株HTB-56/DDP的细胞增殖,并不与DDP交叉耐药。随着小剂量LBP作用时间的延长,细胞的生长抑制呈现浓度与时间的依赖。
|
| 关 键 词： | 支气管肺癌 HTB-56、HTB-56/DDP细胞株 洛铂 MTT |
Research on growth inhibitoty of HTB-56 cells and HTB-56/DDP cells in lung cancer treated with lobaplatin |
| |
| GAO Wen-Bin
,
DENG Rong
,
HAN Pei-Yan
,
HUANG Jian-Hui
,
LI Hua-Ni
,
Ma Jian-Zeng
,
ZHENG Zhen-Zhen
,
FANG Jin-Na.Research on growth inhibitoty of HTB-56 cells and HTB-56/DDP cells in lung cancer treated with lobaplatin[J].Chinese Journal of lung Disease（Electronic Edition）,2012,5(2):137-140. |
| |
| Authors: | GAO Wen-Bin DENG Rong HAN Pei-Yan HUANG Jian-Hui LI Hua-Ni Ma Jian-Zeng ZHENG Zhen-Zhen FANG Jin-Na |
| |
| Institution: | GAO Wen-Bin1, DENG Rong1, HAN Pei-Yan1, HUANG Jian-Hui1, LI Hua-Ni1, MA Jian-Zeng1, ZHENG Zhen-Zhen1, FANG Jin-Nü2 (1Department of Oncology, Appliated Zhongshan Hospital of Dalian University, DaLian 116001; 2 the Office of Pathology and Pathophysiology,School of Medicine, Yanbian University, Yanji 133002) |
| |
| Abstract: | Objective To discuss the effect on growth inhibitoty of lung adenocarcinoma cell treated by lobaplatin (LBP) in different doses, and the relationship between the effects and diverse doses. Methods Human lung adenocarcinoma cell lines HTB-56 and HTB-56/DDT cell lines were treated with different doses and lasting time of LBP to measure the OD (optical density) at different time by MTT, compare the relationships between dose of LBP and the growth control effect. Results LBP can control growth of lung adenocarcinoma cell lines HTB-56 and HTB-56/DDT cell lines which relate to dose and enduring time, control rate was upgrading with the increasing of the dose of LBP and time lasting. Conclusions LBP can control the growth of lung adenocarcinoma cell lines HTB-56 and HTB-56/DDT cell lines. Make sure LBP isn’t cross resistance with DDP. Growth control of lung adenocarcinoma cell related to the dose and enduring time when the continuous low dose of LBP treatment was lasting. |
| |
| Keywords: | Bronchogenic carcinoma HTB-56 HTB-56/DDP cells line Lobaplatin MTT |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
